Abstract
Background
Photodynamic therapy (PDT) has been used to palliate advanced, obstructing, or bleeding esophageal cancers (ECs) and Barrett’s high-grade dysplasia (HGD). Few investigators, though, have described using PDT to cure either disease.
Methods
We performed a retrospective review from 1997–2005 of 50 patients with HGD or EC. All patients refused surgical resection or were physiologically unfit. They were instead treated using PDT with curative intent. Clinical follow-up, long-term survival, complications, and recurrence were evaluated.
Results
Thirteen patients (26%) had Barrett’s HGD, 6 (12%) had small, intramural carcinomas, 16 (32%) had T1 N0 tumors, 14 (28%) had T2 N0 tumors, and 1 (2%) had a small, polypoid T3 lesion. The mean length of follow-up was 28.1 months. Sixteen patients (32%) are alive without recurrence, 15 (30%) are living with residual or recurrent disease and have received additional PDT, and the remainder (38%) died of recurrent EC or other causes and had known recurrence. Sixteen (32%) patients received adjuvant chemotherapy, radiation, or both. Esophageal stricture occurred in 21 (42%) patients. There was no procedure-related mortality.
Conclusions
PDT may represent a reasonable alternate to esophagectomy for high-risk patients with HGD or superficial esophageal cancer. Due to superior survival and local control, we still favor esophagectomy for patients without physiologic impairment. However, PDT appears to potentially cure approximately one-third of superficial esophageal cancers and provide local control of high-grade dysplasia in a similar subset of patients.
Similar content being viewed by others
References
Cancer Facts and Figures 2005, Surveillance Research. American Cancer Society, Atlanta, GA, 2005
McCaughan JS Jr., Guy JT, Hawley P, Hicks W, et al. Hematoporphyrin—derivative and photoablation therapy of malignant tumors. Lasers Surg Med 1983; 3(3):199–209
Dougherty TJ, Kaufman JE, Goldfarb A, Weishaupt KR, et al. Photoradiation therapy for the treatment of malignant tumors. Cancer Res 1978; 38(8):2628–35
Wolfsen HC. Photodynamic therapy for mucosal esophageal adenocarcinoma and dysplastic Barrett’s esophagus. Dig Dis 2002; 20:5–17
Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined [Barrett’s] esophagus. N Engl J Med 1985; 13:857–9
Wolfsen HC. Present status of photodynamic therapy for high-grade dysplasia in Barrett’s esophagus. J Clin Gastroenterol 2005; 39(3):189–202
Rice TW, Falk GW, Achkar E, Petras RE. Surgical management of high-grade dysplasia in Barrett’s esophagus. Am J Gastroenterol 1993; 88:1832–6
Schnell TG, Sontag SJ, Chejfec G, Aranha G, Metz A, O’Connell S, Seidel UJ, et al. Long-term nonsurgical management of Barrett’s esophagus with high-grade dysplasia. Gastroenterology 2001; 120 (7):1607–19
Gerson LB, Groeneveld PW, Triadafilopoulos G. Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease. Gastrohepatol 2004; 2(10):868–79
Shahee NJ, Inadomi JM, Overholt BF, Sharma P. What is the best management strategy for high grade dysplasia in Barrett’s esophagus? A cost effective analysis. Gut 2004; 53(12):1736–44
Chang LC, Oelschlager BK, Quiroga E, Parra JD, Mulligan M, Wood DE, et al. Long-term outcome of esophagectomy for high-grade dysplasia or cancer found during surveillance for Barrett’s esophagus. J Gastrointest Surg 2006; 10(3):341–6
Swanstrom SJ, Batirel HF, Bueno R, et al. Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection for esophageal carcinoma. Ann Thorac Surg 2001; 72:1918–24
Luketich JD, Alvelo-Rivera M, Buenaventura PO, Christie NA, et al. Minimally invasive esophagectomy outcomes in 222 patients. Ann Surg 2003; 238:486–95
Overholt BF, Lightdale DJ, Wang KK, Canto MI, Burdick S. Haggit RC, et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett’s esophagus: international, partially blinded, randomized Phase III trial. Gastrointest Endosc 2005; 62(4):488–98
Moraca RJ, Low DE. Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramural cancer. Arch Surg 2006; 141(6):545–9
Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista L, Welch HG, Wennberg DE Hospital volume and surgical mortality in the United States. N Engl J Med 2002; 346(15):1128–37
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Keeley, S.B., Pennathur, A., Gooding, W. et al. Photodynamic Therapy with Curative Intent for Barrett’s Esophagus with High Grade Dysplasia and Superficial Esophageal Cancer. Ann Surg Oncol 14, 2406–2410 (2007). https://doi.org/10.1245/s10434-007-9392-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-007-9392-x